ECLEVAR MEDTECH, a leading MedTech Contract Research Organization (CRO), has joined forces with DMG ITALIA, an independent company specializing in the development of innovative medical device products. This strategic outsourcing partnership aims to expedite the commercialization of DMG ITALIA’s cutting-edge nasal spray medical devices.
About ECLEVAR MEDTECH
ECLEVAR MEDTECH offers comprehensive end-to-end development services in the MedTech industry. As a Contract Research Organization (CRO), they provide a wide range of solutions to facilitate the development of medical devices. Their expertise and resources enable them to support clients throughout the entire development process.
About DMG ITALIA
DMG ITALIA is a private company known for its dedication to developing innovative medical device products. They specialize in nasal drug delivery and boast a skilled research and development team committed to integrating the latest advancements into their nasal spray device product lines.
The Partnership Benefits
The strategic outsourcing partnership between ECLEVAR MEDTECH and DMG ITALIA provides significant advantages for both companies. Chems HACHANI, CEO of ECLEVAR MEDTECH, expressed satisfaction with the collaboration, emphasizing that DMG ITALIA will gain immediate access to clinical experts and European capacity through this partnership.
Luigi Mercuri, CEO & Managing Director of DMG ITALIA, shared his enthusiasm for the partnership, highlighting the opportunity to expedite the delivery of the latest technology and innovation to physicians and patients.
Addressing Industry Challenges
The MedTech industry faces evolving regulatory requirements and increasing demands for clinical evidence, resulting in longer development timelines, higher costs, and delayed market entry for sponsors. ECLEVAR MEDTECH addresses these challenges with a proactive approach to planning and risk mitigation.
The comprehensive development services offered by ECLEVAR MEDTECH encompass regulatory, reimbursement, and clinical support. By leveraging these services, MedTech innovators can preserve capital, align stakeholders, and ultimately accelerate the commercialization of their products, making them more accessible to patients in need.
Contact Us Now!
If you have any inquiries or would like to learn more about our services, feel free to contact us today!